Philips showcases integrated radiation oncology portfolio to provide a confident path to treatment at ASTRO 2019
September 12 2019 - 9:00AM
Philips showcases integrated radiation oncology portfolio to
provide a confident path to treatment at ASTRO 2019
September 12, 2019
IntelliSpace Radiation Oncology combines all the steps of the
radiotherapy department’s workflow into one platform
Amsterdam, the Netherlands and Chicago, U.S. –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, will showcase its integrated radiation oncology
portfolio at the American Society of Radiation Oncology (ASTRO)
annual meeting (15-18 September in Chicago, U.S.). Visitors to the
Philips booth (#3642) will experience Philips IntelliSpace
Radiation Oncology [1], an intelligent patient management solution
to manage complexity, improve efficiency and enable operational
excellence in radiotherapy departments. The company will also
highlight its Pinnacle Evolution treatment planning software, as
well as its broad portfolio of connected oncology solutions
designed to help health systems achieve the Quadruple Aim: an
improved experience for patients and staff, better health outcomes
and a lower cost of care.
As the number of new cancer cases continues to rise [2], it is
essential that care teams have access to integrated oncology
solutions across all phases of oncology care to enable a more
precise diagnosis, personalized therapy selection and execution,
and better outcomes. Radiotherapy processes in particular can be
fragmented and inefficient. By reducing uncertainties along the
way, care teams can deliver seamless, targeted therapy for each
individual patient.
“While significant strides have been made in oncology over the
past decade, treating cancer is more complex than ever before –
especially for radiotherapy, due to the number of clinical
specialists and advanced technologies required to deliver effective
care,” said Ardie Ermers, General Manager Radiation Oncology,
Philips. “At Philips, we’re focused on delivering intelligent,
integrated oncology solutions to help improve outcomes across
multiple disciplines and clinical
settings.” IntelliSpace Radiation Oncology
[1], the latest addition to Philips’ renewed suite of
radiation oncology systems and software, provides a harmonized way
of working, integrating applications from partners including MIM
Software Inc and Sun Nuclear, and automating workflow to help
reduce the amount of time it takes from receiving a patient
referral to the start of their treatment. In addition, Philips’
recently launched Radiation Oncology Practice
Management [1], a consultancy service to help radiotherapy
departments capitalize on the insights and workflow improvement
opportunities presented by the platform.
The South West Wales Cancer Centre (SWWCC) in the UK is among
the first partner sites that will implement Philips IntelliSpace
Radiation Oncology and associated practice management solutions.
“This new solution should help our patients directly by improving
their experience and decreasing their time to treatment,” said Dr.
Russell Banner, Clinical Oncologist and Radiotherapy Lead at the
SWWCC. “Furthermore, it will allow us to manage our workflows
within our department, seeing where patients are within the often
complex treatment pathways.”
Imaging plays a critical role in understanding tumor
characteristics, increasing accuracy of therapy delivery, and
better assessing patient response to treatment. On-site this year,
Philips will feature Pinnacle Evolution, the
latest generation of the Philips Pinnacle treatment planning
software, as well as several imaging systems, including Philips’
dedicated oncology CT simulator, Big Bore RT, as
well as the Ingenia Elition 3.0T MR-RT and
Ambition 1.5T MR-RT systems.
Philips’ end-to-end oncology solutionsPhilips’
radiation oncology portfolio complements the company’s IntelliSpace
Precision Medicine oncology solutions portfolio, which integrates
diagnostics and therapy selection to drive clinical, operational
and financial benefits for healthcare providers. The company's
oncology solutions portfolio includes:
- Oncology Pathways – high-quality, detailed,
evidence-based oncology treatment protocols powered by Dana-Farber,
allowing clinical users to navigate through the branches of
pathways to make clinical decisions and provide treatment plan
recommendations, including clinical trials.
- Oncology Platform [3] – a comprehensive
platform for use in multi-disciplinary (and molecular) tumor board
meetings, which integrates data from hospital information systems
across different clinical domains including radiology, pathology,
and genomics, to enable a detailed view of the patient and care
path to facilitate cross-disciplinary collaboration and
communication.
- Pathology – Philips’ IntelliSite Pathology
Solution, the first FDA-approved digital pathology solution to be
marketed for primary diagnostic use to reduce pressure on pathology
services by streamlining workflows and extending collaboration to
help increase diagnostic confidence.
- Genomics [3] – an end-to-end precision
medicine platform that automates pathologists’ workflows through
collaboration with oncologists and peers, enabling genomic
interpretation and therapy recommendation based on a single,
comprehensive patient view, which also includes OncoSignal [4]
signaling pathway activity analysis to reveal tumor-driving
mechanisms.
For more information about Philips’ presence at ASTRO 2019 visit
the Philips event website and follow @PhilipsLiveFrom for updates
throughout #ASTRO19.
[1] IntelliSpace Radiation Oncology and Radiation Oncology
Practice Management are considered works in progress and are not
available for sale.[2] The number of new cancer cases expected to
rise by an estimated 70% over the next two decades. WHO cancer fact
sheet No 297. Updated February 2015
http://www.who.int/mediacentre/factsheets/fs297/en/.[3] Not
available for sale in all countries.[4] For research use only. Not
for use in diagnostic procedures.
For further information, please contact:
Kathy O’ReillyPhilips Global Press OfficeTel.: +1 978 221
8919E-mail: kathy.oreilly@philips.comTwitter: @kathyoreilly
Mark GrovesPhilips Global Press OfficeTel.: +31 631 639
916Email: mark.groves@philips.comTwitter: @mark_groves
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2018
sales of EUR 18.1 billion and employs approximately 78,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Philips IntelliSpace Radiation Oncology
- Philips IntelliSpace Radiation Oncology Dialog
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024